Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use

Grants

Funding Acknowledgements

Thanks to Lydia Windisch for practical assistance, Emeritus Professor Kim Ng for methodological consultation and Drs Jon Cole, Mitch Earleywine and Brady Reynolds for comments on this article. We also thank the participants. G. B. was supported by an Australian Postgraduate Award, and the project was funded by Monash University, School of Psychology, Psychiatry, and Psychological Medicine.